<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;ff=20250315161108&amp;v=2.18.0.post9+e462414&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;fc=20230708114047&amp;utm_campaign=pubmed-2
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;ff=20250315161108&amp;v=2.18.0.post9+e462414&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;fc=20230708114047&amp;utm_campaign=pubmed-2" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Sat, 15 Mar 2025 20:11:09 +0000</lastbuilddate>
<pubDate>Fri, 14 Mar 2025 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>The year in cardiovascular medicine 2024: the top 10 papers in thrombosis and antithrombotic treatment</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40084811/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250315161108&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Mar 14:ehaf126. doi: 10.1093/eurheartj/ehaf126. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40084811/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250315161108&v=2.18.0.post9+e462414">40084811</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf126>10.1093/eurheartj/ehaf126</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40084811</guid>
<pubDate>Fri, 14 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Felicita Andreotti</dc:creator>
<dc:creator>Jurriën M Ten Berg</dc:creator>
<dc:creator>Michelle L O'Donoghue</dc:creator>
<dc:date>2025-03-14</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>The year in cardiovascular medicine 2024: the top 10 papers in thrombosis and antithrombotic treatment</dc:title>
<dc:identifier>pmid:40084811</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf126</dc:identifier>
</item>
<item>
<title>Hereditary Transthyretin Cardiac Amyloidosis With the p.V142I Variant: Mechanistic Insights and Diagnostic Challenges</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40084403/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250315161108&amp;v=2.18.0.post9+e462414
      <description>The most common form of hereditary transthyretin cardiac amyloidosis (hATTR-CA) in the United States and the United Kingdom is the p.V142I variant. About 3% to 4% of patients with African ancestry carry this genetic predisposition to develop signs and symptoms of hATTR-CA. Nevertheless, clinical manifestations of hATTR-CA appear only late in the fifth and sixth decades of life, despite its clear genetic background. Imbalances in native protein-stabilizing and elementary breakdown cellular...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Heart Fail. 2025 Mar 14:e012469. doi: 10.1161/CIRCHEARTFAILURE.124.012469. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The most common form of hereditary transthyretin cardiac amyloidosis (hATTR-CA) in the United States and the United Kingdom is the p.V142I variant. About 3% to 4% of patients with African ancestry carry this genetic predisposition to develop signs and symptoms of hATTR-CA. Nevertheless, clinical manifestations of hATTR-CA appear only late in the fifth and sixth decades of life, despite its clear genetic background. Imbalances in native protein-stabilizing and elementary breakdown cellular mechanisms are postulated as potential causes for affecting transthyretin structural integrity and myocardial fibril deposition. Noncoding variants, epigenetic and environmental factors, as well as gut microbiome derangements may serve as disease-modifying factors that feature detrimental amyloidogenic organ involvement and impact disease severity. Organ amyloid deposition varies widely among different carriers of a genetic transthyretin variant. The genotype-phenotype interdependence causes unpredictable phenotypic penetrance that results in a variety of signs and symptoms and patient outcomes. Cardiovascular biomarkers and multimodality imaging may identify initial amyloidogenic organ involvement. These early clinical clues through the course of hATTR-CA offer a window of opportunity for early treatment onset to cease disease progression and alter prognosis. Identifying at-risk patients requires information on the genetic background of probands and their relatives. Initiatives to reveal asymptomatic gene carriers early in the disease should be encouraged, as it necessitates stringent patient follow-up and immediate treatment onset to reduce the burden of heart failure hospitalization and mortality in hATTR-CA.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40084403/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250315161108&v=2.18.0.post9+e462414">40084403</a> | DOI:<a href=https://doi.org/10.1161/CIRCHEARTFAILURE.124.012469>10.1161/CIRCHEARTFAILURE.124.012469</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40084403</guid>
<pubDate>Fri, 14 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Simon Vanhentenrijk</dc:creator>
<dc:creator>Justin L Grodin</dc:creator>
<dc:creator>Silvio Nunes Augusto</dc:creator>
<dc:creator>W H Wilson Tang</dc:creator>
<dc:date>2025-03-14</dc:date>
<dc:source>Circulation. Heart failure</dc:source>
<dc:title>Hereditary Transthyretin Cardiac Amyloidosis With the p.V142I Variant: Mechanistic Insights and Diagnostic Challenges</dc:title>
<dc:identifier>pmid:40084403</dc:identifier>
<dc:identifier>doi:10.1161/CIRCHEARTFAILURE.124.012469</dc:identifier>
</item>
<item>
<title>An unanticipated cause of worsening dyspnoea: mitral stenosis induced by cardiac myxoma</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40084280/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250315161108&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Imaging Methods Pract. 2025 Feb 26;3(1):qyaf024. doi: 10.1093/ehjimp/qyaf024. eCollection 2025 Jan.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40084280/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250315161108&v=2.18.0.post9+e462414">40084280</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11905737/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250315161108&v=2.18.0.post9+e462414">PMC11905737</a> | DOI:<a href=https://doi.org/10.1093/ehjimp/qyaf024>10.1093/ehjimp/qyaf024</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40084280</guid>
<pubDate>Fri, 14 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Deniz Mutlu</dc:creator>
<dc:creator>Hakan Yalman</dc:creator>
<dc:creator>Mehmet Semih Belpınar</dc:creator>
<dc:creator>Anıl Şahin</dc:creator>
<dc:creator>Zafer Akman</dc:creator>
<dc:creator>Davide Margonato</dc:creator>
<dc:date>2025-03-14</dc:date>
<dc:source>European heart journal. Imaging methods and practice</dc:source>
<dc:title>An unanticipated cause of worsening dyspnoea: mitral stenosis induced by cardiac myxoma</dc:title>
<dc:identifier>pmid:40084280</dc:identifier>
<dc:identifier>pmc:PMC11905737</dc:identifier>
<dc:identifier>doi:10.1093/ehjimp/qyaf024</dc:identifier>
</item>
<item>
<title>Intracardiac flow dynamics in mitral regurgitation: state of the art</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40084279/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250315161108&amp;v=2.18.0.post9+e462414
      <description>Intracardiac flow dynamics is a complex phenomenon interrelated with cardiac mechanics. Today, it can be evaluated non-invasively using various imaging modalities, including echocardiography, magnetic resonance imaging, and computed tomography. This review explores the effects of mitral regurgitation on blood flow dynamics inside the left ventricular and atrial cavities and emphasizes the disruption of normal flow dynamics caused by mitral regurgitation, leading to turbulent flow and increased...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Imaging Methods Pract. 2025 Feb 19;3(1):qyaf022. doi: 10.1093/ehjimp/qyaf022. eCollection 2025 Jan.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Intracardiac flow dynamics is a complex phenomenon interrelated with cardiac mechanics. Today, it can be evaluated non-invasively using various imaging modalities, including echocardiography, magnetic resonance imaging, and computed tomography. This review explores the effects of mitral regurgitation on blood flow dynamics inside the left ventricular and atrial cavities and emphasizes the disruption of normal flow dynamics caused by mitral regurgitation, leading to turbulent flow and increased energy dissipation. It further examines the consequences of mitral valve repair and replacement, noting that, while repair generally improves intracardiac flow dynamics compared with replacement, residual flow disturbances may persist. Finally, the implications of abnormal intracardiac vorticity on left ventricular wall stress, myocardial remodelling, and thromboembolic risk are discussed.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40084279/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250315161108&v=2.18.0.post9+e462414">40084279</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11904890/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250315161108&v=2.18.0.post9+e462414">PMC11904890</a> | DOI:<a href=https://doi.org/10.1093/ehjimp/qyaf022>10.1093/ehjimp/qyaf022</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40084279</guid>
<pubDate>Fri, 14 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Lorenzo Serio</dc:creator>
<dc:creator>Riccardo Beccari</dc:creator>
<dc:creator>Stefano Nistri</dc:creator>
<dc:creator>Antonella Cecchetto</dc:creator>
<dc:creator>Gianni Pedrizzetti</dc:creator>
<dc:creator>Donato Mele</dc:creator>
<dc:date>2025-03-14</dc:date>
<dc:source>European heart journal. Imaging methods and practice</dc:source>
<dc:title>Intracardiac flow dynamics in mitral regurgitation: state of the art</dc:title>
<dc:identifier>pmid:40084279</dc:identifier>
<dc:identifier>pmc:PMC11904890</dc:identifier>
<dc:identifier>doi:10.1093/ehjimp/qyaf022</dc:identifier>
</item>
<item>
<title>Relapsing pericarditis mimicking aortic dissection</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40083627/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250315161108&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Case Rep. 2025 Feb 27;9(3):ytaf111. doi: 10.1093/ehjcr/ytaf111. eCollection 2025 Mar.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40083627/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250315161108&v=2.18.0.post9+e462414">40083627</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11905975/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250315161108&v=2.18.0.post9+e462414">PMC11905975</a> | DOI:<a href=https://doi.org/10.1093/ehjcr/ytaf111>10.1093/ehjcr/ytaf111</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40083627</guid>
<pubDate>Fri, 14 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Yoshiko Eto</dc:creator>
<dc:creator>Nobuhiro Tahara</dc:creator>
<dc:creator>Yoshihiro Fukumoto</dc:creator>
<dc:date>2025-03-14</dc:date>
<dc:source>European heart journal. Case reports</dc:source>
<dc:title>Relapsing pericarditis mimicking aortic dissection</dc:title>
<dc:identifier>pmid:40083627</dc:identifier>
<dc:identifier>pmc:PMC11905975</dc:identifier>
<dc:identifier>doi:10.1093/ehjcr/ytaf111</dc:identifier>
</item>
<item>
<title>The duo of precision imaging: computed tomography and optical coherence tomography give new opportunities for the diagnosis and conservative treatment of coronary plaque erosion-a case report</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40083626/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250315161108&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Case Rep. 2025 Feb 27;9(3):ytaf099. doi: 10.1093/ehjcr/ytaf099. eCollection 2025 Mar.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40083626/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250315161108&v=2.18.0.post9+e462414">40083626</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11905885/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250315161108&v=2.18.0.post9+e462414">PMC11905885</a> | DOI:<a href=https://doi.org/10.1093/ehjcr/ytaf099>10.1093/ehjcr/ytaf099</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40083626</guid>
<pubDate>Fri, 14 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Denitsa Meteva</dc:creator>
<dc:creator>Elaaha Anwari</dc:creator>
<dc:creator>Ulf Landmesser</dc:creator>
<dc:creator>Youssef S Abdelwahed</dc:creator>
<dc:date>2025-03-14</dc:date>
<dc:source>European heart journal. Case reports</dc:source>
<dc:title>The duo of precision imaging: computed tomography and optical coherence tomography give new opportunities for the diagnosis and conservative treatment of coronary plaque erosion-a case report</dc:title>
<dc:identifier>pmid:40083626</dc:identifier>
<dc:identifier>pmc:PMC11905885</dc:identifier>
<dc:identifier>doi:10.1093/ehjcr/ytaf099</dc:identifier>
</item>
<item>
<title>A unique presentation of systolic anterior motion of the mitral valve in a patient with obstructive hypertrophic cardiomyopathy and recurrent syncope: a case report</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40083625/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250315161108&amp;v=2.18.0.post9+e462414
      <description>BACKGROUND: Systolic anterior motion (SAM) of the mitral valve is a hallmark feature of hypertrophic obstructive cardiomyopathy (HOCM) and a primary cause of dynamic left ventricular outflow tract obstruction. This case report highlights an unusual presentation of SAM associated with acute haemodynamic collapse.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Case Rep. 2025 Mar 13;9(3):ytaf103. doi: 10.1093/ehjcr/ytaf103. eCollection 2025 Mar.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Systolic anterior motion (SAM) of the mitral valve is a hallmark feature of hypertrophic obstructive cardiomyopathy (HOCM) and a primary cause of dynamic left ventricular outflow tract obstruction. This case report highlights an unusual presentation of SAM associated with acute haemodynamic collapse.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CASE SUMMARY: A 36-year-old male with HOCM presented with recurrent episodes of syncope. After a multidisciplinary evaluation, he underwent percutaneous intramyocardial septal radiofrequency ablation (PIMSRA). Approximately 1-h post-procedure, the patient developed severe haemodynamic collapse. Transthoracic echocardiography revealed abnormal proximal displacement of the anterior mitral valve leaflet, bringing it into close proximity with the septum. The patient was treated emergently with high-dose intravenous norepinephrine, stabilizing his condition. At the 18-month follow-up, the patient reported no recurrence of syncope.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DISCUSSION: Proximal displacement of the anterior mitral leaflet, a rare and severe form of SAM, is an uncommon yet critical complication associated with haemodynamic collapse and syncope. This phenomenon warrants heightened attention during PIMSRA for the treatment of HOCM.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40083625/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250315161108&v=2.18.0.post9+e462414">40083625</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11905931/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250315161108&v=2.18.0.post9+e462414">PMC11905931</a> | DOI:<a href=https://doi.org/10.1093/ehjcr/ytaf103>10.1093/ehjcr/ytaf103</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40083625</guid>
<pubDate>Fri, 14 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Wenxia Li</dc:creator>
<dc:creator>Jing Ping Sun</dc:creator>
<dc:creator>Chao Han</dc:creator>
<dc:creator>Shengjun Ta</dc:creator>
<dc:creator>Liwen Liu</dc:creator>
<dc:date>2025-03-14</dc:date>
<dc:source>European heart journal. Case reports</dc:source>
<dc:title>A unique presentation of systolic anterior motion of the mitral valve in a patient with obstructive hypertrophic cardiomyopathy and recurrent syncope: a case report</dc:title>
<dc:identifier>pmid:40083625</dc:identifier>
<dc:identifier>pmc:PMC11905931</dc:identifier>
<dc:identifier>doi:10.1093/ehjcr/ytaf103</dc:identifier>
</item>
<item>
<title>Little-known complication: acute type B aortic dissection during transcatheter edge-to-edge repair for mitral regurgitation</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40083624/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250315161108&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Case Rep. 2025 Feb 25;9(3):ytaf091. doi: 10.1093/ehjcr/ytaf091. eCollection 2025 Mar.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40083624/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250315161108&v=2.18.0.post9+e462414">40083624</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11905886/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250315161108&v=2.18.0.post9+e462414">PMC11905886</a> | DOI:<a href=https://doi.org/10.1093/ehjcr/ytaf091>10.1093/ehjcr/ytaf091</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40083624</guid>
<pubDate>Fri, 14 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Fumiya Chubachi</dc:creator>
<dc:creator>Arudo Hiraoka</dc:creator>
<dc:creator>Takao Morikawa</dc:creator>
<dc:date>2025-03-14</dc:date>
<dc:source>European heart journal. Case reports</dc:source>
<dc:title>Little-known complication: acute type B aortic dissection during transcatheter edge-to-edge repair for mitral regurgitation</dc:title>
<dc:identifier>pmid:40083624</dc:identifier>
<dc:identifier>pmc:PMC11905886</dc:identifier>
<dc:identifier>doi:10.1093/ehjcr/ytaf091</dc:identifier>
</item>
<item>
<title>Simultaneous CRISPR screening and spatial transcriptomics reveal intracellular, intercellular, and functional transcriptional circuits</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40081369/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250315161108&amp;v=2.18.0.post9+e462414
      <description>Pooled optical screens have enabled the study of cellular interactions, morphology, or dynamics at massive scale, but they have not yet leveraged the power of highly plexed single-cell resolved transcriptomic readouts to inform molecular pathways. Here, we present a combination of imaging spatial transcriptomics with parallel optical detection of in situ amplified guide RNAs (Perturb-FISH). Perturb-FISH recovers intracellular effects that are consistent with single-cell RNA-sequencing-based...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2025 Mar 10:S0092-8674(25)00197-7. doi: 10.1016/j.cell.2025.02.012. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Pooled optical screens have enabled the study of cellular interactions, morphology, or dynamics at massive scale, but they have not yet leveraged the power of highly plexed single-cell resolved transcriptomic readouts to inform molecular pathways. Here, we present a combination of imaging spatial transcriptomics with parallel optical detection of in situ amplified guide RNAs (Perturb-FISH). Perturb-FISH recovers intracellular effects that are consistent with single-cell RNA-sequencing-based readouts of perturbation effects (Perturb-seq) in a screen of lipopolysaccharide response in cultured monocytes, and it uncovers intercellular and density-dependent regulation of the innate immune response. Similarly, in three-dimensional xenograft models, Perturb-FISH identifies tumor-immune interactions altered by genetic knockout. When paired with a functional readout in a separate screen of autism spectrum disorder risk genes in human-induced pluripotent stem cell (hIPSC) astrocytes, Perturb-FISH shows common calcium activity phenotypes and their associated genetic interactions and dysregulated molecular pathways. Perturb-FISH is thus a general method for studying the genetic and molecular associations of spatial and functional biology at single-cell resolution.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40081369/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250315161108&v=2.18.0.post9+e462414">40081369</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2025.02.012>10.1016/j.cell.2025.02.012</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40081369</guid>
<pubDate>Thu, 13 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Loϊc Binan</dc:creator>
<dc:creator>Aiping Jiang</dc:creator>
<dc:creator>Serwah A Danquah</dc:creator>
<dc:creator>Vera Valakh</dc:creator>
<dc:creator>Brooke Simonton</dc:creator>
<dc:creator>Jon Bezney</dc:creator>
<dc:creator>Robert T Manguso</dc:creator>
<dc:creator>Kathleen B Yates</dc:creator>
<dc:creator>Ralda Nehme</dc:creator>
<dc:creator>Brian Cleary</dc:creator>
<dc:creator>Samouil L Farhi</dc:creator>
<dc:date>2025-03-13</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Simultaneous CRISPR screening and spatial transcriptomics reveal intracellular, intercellular, and functional transcriptional circuits</dc:title>
<dc:identifier>pmid:40081369</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2025.02.012</dc:identifier>
</item>
<item>
<title>Crop root bacterial and viral genomes reveal unexplored species and microbiome patterns</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40081368/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250315161108&amp;v=2.18.0.post9+e462414
      <description>Reference genomes of root microbes are essential for metagenomic analyses and mechanistic studies of crop root microbiomes. By combining high-throughput bacterial cultivation with metagenomic sequencing, we constructed comprehensive bacterial and viral genome collections from the roots of wheat, rice, maize, and Medicago. The crop root bacterial genome collection (CRBC) significantly expands the quantity and phylogenetic diversity of publicly available crop root bacterial genomes, with 6,699...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2025 Mar 10:S0092-8674(25)00198-9. doi: 10.1016/j.cell.2025.02.013. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Reference genomes of root microbes are essential for metagenomic analyses and mechanistic studies of crop root microbiomes. By combining high-throughput bacterial cultivation with metagenomic sequencing, we constructed comprehensive bacterial and viral genome collections from the roots of wheat, rice, maize, and Medicago. The crop root bacterial genome collection (CRBC) significantly expands the quantity and phylogenetic diversity of publicly available crop root bacterial genomes, with 6,699 bacterial genomes (68.9% from isolates) and 1,817 undefined species, expanding crop root bacterial diversity by 290.6%. The crop root viral genome collection (CRVC) contains 9,736 non-redundant viral genomes, with 1,572 previously unreported genus-level clusters in crop root microbiomes. From these, we identified conserved bacterial functions enriched in root microbiomes across soils and host species and uncovered previously unexplored bacteria-virus connections in crop root ecosystems. Together, the CRBC and CRVC serve as valuable resources for investigating microbial mechanisms and applications, supporting sustainable agriculture.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40081368/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250315161108&v=2.18.0.post9+e462414">40081368</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2025.02.013>10.1016/j.cell.2025.02.013</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40081368</guid>
<pubDate>Thu, 13 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Rui Dai</dc:creator>
<dc:creator>Jingying Zhang</dc:creator>
<dc:creator>Fang Liu</dc:creator>
<dc:creator>Haoran Xu</dc:creator>
<dc:creator>Jing-Mei Qian</dc:creator>
<dc:creator>Shani Cheskis</dc:creator>
<dc:creator>Weidong Liu</dc:creator>
<dc:creator>Binglei Wang</dc:creator>
<dc:creator>Honghui Zhu</dc:creator>
<dc:creator>Lotte J U Pronk</dc:creator>
<dc:creator>Marnix H Medema</dc:creator>
<dc:creator>Ronnie de Jonge</dc:creator>
<dc:creator>Corné M J Pieterse</dc:creator>
<dc:creator>Asaf Levy</dc:creator>
<dc:creator>Klaus Schlaeppi</dc:creator>
<dc:creator>Yang Bai</dc:creator>
<dc:date>2025-03-13</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Crop root bacterial and viral genomes reveal unexplored species and microbiome patterns</dc:title>
<dc:identifier>pmid:40081368</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2025.02.013</dc:identifier>
</item>
<item>
<title>Long-term Prognostic Value of Left and Right Ventricular Systolic Function on Cardiovascular Magnetic Resonance Imaging in Systemic Sclerosis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40080673/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250315161108&amp;v=2.18.0.post9+e462414
      <description>CONCLUSION: In patients with SSc and clinically suspected cardiac disease, worse LVGLS and RVGLS on CMR were independently associated with death or MACE, while LVEF and RVEF were not.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Cardiovasc Imaging. 2025 Mar 13:jeaf086. doi: 10.1093/ehjci/jeaf086. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIMS: Systemic sclerosis (SSc) is a rare autoimmune disorder associated with a high risk of cardiovascular diseases. We aimed to determine the long-term prognostic value of left and right ventricular (LV and RV) systolic dysfunction in SSc patients with clinically suspected cardiac disease.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS AND RESULTS: We conducted a retrospective cohort study of consecutive adults with SSc who had cardiovascular magnetic resonance imaging (CMR) for suspected cardiac disease. We assessed two CMR measures of LV and RV function, ejection fraction (EF) and feature tracking-derived global longitudinal strain (GLS), and investigated their associations with the long-term incidence of a composite endpoint of death or major adverse cardiac events (MACE). In 151 patients (median age 58 years, 81% women) who had CMR at a median of 3.6 years after diagnosis, the median LVEF was 58.0%, and the median LVGLS was -15.7%. The median RVEF was 57.0%, and the median RVGLS was -16.2%. Over a median follow-up of 4.7 years, 69 patients experienced the composite endpoint of death or MACE. LVGLS was independently associated with the composite endpoint (hazard ratio [HR] 1.08 per 1% worsening; 95% confidence interval [CI] 1.01-1.15; p = 0.018), while LVEF was not. Similarly, RVGLS was independently associated with the composite endpoint (HR 1.08 per 1% worsening; 95% CI 1.01-1.15; p = 0.017), while RVEF was not.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: In patients with SSc and clinically suspected cardiac disease, worse LVGLS and RVGLS on CMR were independently associated with death or MACE, while LVEF and RVEF were not.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40080673/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250315161108&v=2.18.0.post9+e462414">40080673</a> | DOI:<a href=https://doi.org/10.1093/ehjci/jeaf086>10.1093/ehjci/jeaf086</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40080673</guid>
<pubDate>Thu, 13 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Parag Bawaskar</dc:creator>
<dc:creator>Sanya Chhikara</dc:creator>
<dc:creator>Yugene Guo</dc:creator>
<dc:creator>Pal Satyajit Singh Athwal</dc:creator>
<dc:creator>Chetan Shenoy</dc:creator>
<dc:date>2025-03-13</dc:date>
<dc:source>European heart journal. Cardiovascular Imaging</dc:source>
<dc:title>Long-term Prognostic Value of Left and Right Ventricular Systolic Function on Cardiovascular Magnetic Resonance Imaging in Systemic Sclerosis</dc:title>
<dc:identifier>pmid:40080673</dc:identifier>
<dc:identifier>doi:10.1093/ehjci/jeaf086</dc:identifier>
</item>
<item>
<title>Advances in Our Understanding of Cardiovascular Diseases After Preeclampsia</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40080539/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250315161108&amp;v=2.18.0.post9+e462414
      <description>Preeclampsia is a syndrome of hypertension in association with target organ dysfunction, including proteinuria, which manifests during pregnancy and the immediate postpartum period. The pathophysiology of preeclampsia originates from impaired trophoblastic invasion of the placental resulting in malperfusion and involves multiple mechanistic pathways that include anti-angiogenic factors, endothelial dysfunction, and immune dysregulation. Preeclampsia caries an increased risk of subclinical...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2025 Mar 14;136(6):583-593. doi: 10.1161/CIRCRESAHA.124.325581. Epub 2025 Mar 13.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Preeclampsia is a syndrome of hypertension in association with target organ dysfunction, including proteinuria, which manifests during pregnancy and the immediate postpartum period. The pathophysiology of preeclampsia originates from impaired trophoblastic invasion of the placental resulting in malperfusion and involves multiple mechanistic pathways that include anti-angiogenic factors, endothelial dysfunction, and immune dysregulation. Preeclampsia caries an increased risk of subclinical cardiovascular disease including left ventricular remodeling, diastolic dysfunction, coronary artery calcification, peripheral vascular abnormalities, and microvascular dysfunction and clinical cardiovascular disease including stroke, heart failure, myocardial infarction, and death from a cardiovascular cause. This review will highlight several common mechanistic pathways shared between preeclampsia and cardiovascular diseases that provide insight into potential targets for risk reduction and disease process mitigation that can be examined in future trials.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40080539/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250315161108&v=2.18.0.post9+e462414">40080539</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.325581>10.1161/CIRCRESAHA.124.325581</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40080539</guid>
<pubDate>Thu, 13 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Malamo E Countouris</dc:creator>
<dc:creator>Natalie A Bello</dc:creator>
<dc:date>2025-03-13</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Advances in Our Understanding of Cardiovascular Diseases After Preeclampsia</dc:title>
<dc:identifier>pmid:40080539</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.325581</dc:identifier>
</item>
<item>
<title>Understanding Thoracic Aortic Disease in Women</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40080538/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250315161108&amp;v=2.18.0.post9+e462414
      <description>Multifaceted disparities exist between men and women with thoracic aortic aneurysm and dissection. Despite a higher prevalence of thoracic aortic aneurysm and dissection among men, women experience disproportionately accelerated aneurysmal expansion, greater risks of rupture or dissection, and acute aortic syndromes that occur at relatively smaller diameters. In the context of acute type A aortic dissection, they also experience more complications, increased out-of-hospital mortality, delays in...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2025 Mar 14;136(6):606-617. doi: 10.1161/CIRCRESAHA.124.325681. Epub 2025 Mar 13.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Multifaceted disparities exist between men and women with thoracic aortic aneurysm and dissection. Despite a higher prevalence of thoracic aortic aneurysm and dissection among men, women experience disproportionately accelerated aneurysmal expansion, greater risks of rupture or dissection, and acute aortic syndromes that occur at relatively smaller diameters. In the context of acute type A aortic dissection, they also experience more complications, increased out-of-hospital mortality, delays in presentation and diagnosis, and worse postoperative survival. These gaps are largely driven by sex differences in vascular aging and remodeling, which include arterial stiffening associated with the hormonal changes that occur during menopause. Furthermore, the increased risk of acute type A aortic dissection during pregnancy in women with thoracic aortic disease necessitates a multidisciplinary approach to peripartum counseling and surveillance. Despite significant recent improvements in early postoperative outcomes, other disparities persist, emphasizing the need for sex-specific research, patient counseling, routine monitoring, and surgical thresholds to bridge the gap in outcomes of thoracic aortic care between sexes. Elucidating the underlying mechanisms of aortic aging and its difference between men and women, as well as moving toward personalized management protocols, will give rise to improved outcomes in the treatment of thoracic aortopathy.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40080538/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250315161108&v=2.18.0.post9+e462414">40080538</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.325681>10.1161/CIRCRESAHA.124.325681</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40080538</guid>
<pubDate>Thu, 13 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Bana Samman</dc:creator>
<dc:creator>Mimi X Deng</dc:creator>
<dc:creator>Jennifer C Y Chung</dc:creator>
<dc:creator>Maral Ouzounian</dc:creator>
<dc:date>2025-03-13</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Understanding Thoracic Aortic Disease in Women</dc:title>
<dc:identifier>pmid:40080538</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.325681</dc:identifier>
</item>
<item>
<title>Introduction to the Compendium on Lifelong Care in Women: Applying a Sex- and Gender-Lens to Practice</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40080537/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250315161108&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2025 Mar 14;136(6):551-552. doi: 10.1161/CIRCRESAHA.125.326335. Epub 2025 Mar 13.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40080537/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250315161108&v=2.18.0.post9+e462414">40080537</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.125.326335>10.1161/CIRCRESAHA.125.326335</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40080537</guid>
<pubDate>Thu, 13 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Kathryn J Lindley</dc:creator>
<dc:date>2025-03-13</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Introduction to the Compendium on Lifelong Care in Women: Applying a Sex- and Gender-Lens to Practice</dc:title>
<dc:identifier>pmid:40080537</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.125.326335</dc:identifier>
</item>
<item>
<title>Lifelong Care of Females With Congenital Heart Disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40080536/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250315161108&amp;v=2.18.0.post9+e462414
      <description>Medical and surgical advancements of the past 70 years have resulted in a remarkable shift in the natural history of congenital heart disease (CHD) such that survival to adulthood is expected for >;90% of children born with congenital heart defects, including those with complex CHD. There are now more adults than children living with CHD, a majority of them are female. As significant strides have been made in the management of adult patients with CHD, there has been an evolving understanding of...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2025 Mar 14;136(6):553-565. doi: 10.1161/CIRCRESAHA.124.325596. Epub 2025 Mar 13.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Medical and surgical advancements of the past 70 years have resulted in a remarkable shift in the natural history of congenital heart disease (CHD) such that survival to adulthood is expected for >;90% of children born with congenital heart defects, including those with complex CHD. There are now more adults than children living with CHD, a majority of them are female. As significant strides have been made in the management of adult patients with CHD, there has been an evolving understanding of the important role inherent sex-specific differences play in impacting long-term outcomes for females with CHD including differences in sexual and reproductive health, risk and incidence of acquired cardiovascular disease, and health surveillance. Notably, care for the female CHD patient is a continuum that is not isolated to discrete stages but cumulative of health exposures and experiences over a lifetime. This review aims to provide a brief overview of the current understanding of the unique health needs and considerations for females with CHD over their lifetime for both the pediatric and adult provider to help identify opportunities for care optimization, continue to raise awareness of the necessity of lifelong care and advocate for the critical need of research that prospectively evaluates pregnancy and other health-related exposures on long-term quality of life and survival for females with CHD.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40080536/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250315161108&v=2.18.0.post9+e462414">40080536</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.325596>10.1161/CIRCRESAHA.124.325596</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40080536</guid>
<pubDate>Thu, 13 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Rose Tompkins</dc:creator>
<dc:creator>Prashanth Venkatesh</dc:creator>
<dc:creator>Adam J Small</dc:creator>
<dc:creator>Dan G Halpern</dc:creator>
<dc:date>2025-03-13</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Lifelong Care of Females With Congenital Heart Disease</dc:title>
<dc:identifier>pmid:40080536</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.325596</dc:identifier>
</item>
<item>
<title>Strategies for Overcoming Barriers in Access to Cardiovascular Care for Women</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40080535/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250315161108&amp;v=2.18.0.post9+e462414
      <description>Women face unique barriers to equitable health care. To ensure access to quality cardiovascular care across the lifespan of women, several systemic and social challenges need to be addressed. With the understanding that women often direct health care decisions, not only for themselves but for their family unit as well, a holistic approach to address health care barriers is warranted. This review aims to highlight key barriers to equitable health care access for women and propose potential...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2025 Mar 14;136(6):628-641. doi: 10.1161/CIRCRESAHA.124.325544. Epub 2025 Mar 13.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Women face unique barriers to equitable health care. To ensure access to quality cardiovascular care across the lifespan of women, several systemic and social challenges need to be addressed. With the understanding that women often direct health care decisions, not only for themselves but for their family unit as well, a holistic approach to address health care barriers is warranted. This review aims to highlight key barriers to equitable health care access for women and propose potential strategies to overcome these barriers. This review is structured around 5 key areas in which there are gender- or sex-specific barriers to optimal outcomes: (1) insurance-related barriers, (2) geographic and social barriers, (3) health care delivery capacity and workforce issues, (4) quality and accountability measures, and (5) global health challenges. More research is needed on the sustainability, costs, and sex- and gender-specific outcomes of these solutions to drive transformative change.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40080535/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250315161108&v=2.18.0.post9+e462414">40080535</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.325544>10.1161/CIRCRESAHA.124.325544</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40080535</guid>
<pubDate>Thu, 13 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Deirdre J Mattina</dc:creator>
<dc:creator>Michael C Honigberg</dc:creator>
<dc:creator>Zainab Mahmoud</dc:creator>
<dc:creator>Karen E Joynt Maddox</dc:creator>
<dc:date>2025-03-13</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Strategies for Overcoming Barriers in Access to Cardiovascular Care for Women</dc:title>
<dc:identifier>pmid:40080535</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.325544</dc:identifier>
</item>
<item>
<title>Influence of Primary Neurologic Disease on Cardiovascular Health in Females</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40080534/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250315161108&amp;v=2.18.0.post9+e462414
      <description>Neurocardiology is an interdisciplinary field that examines the complex interactions between the nervous and the cardiovascular systems, exploring how neurological processes, such as autonomic nervous system regulation and brain-heart communication impact heart function and contribute to cardiovascular health and disease. Although much of the focus on cardiovascular health has centered on traditional risk factors, the influence of the nervous system, especially in females, is increasingly...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2025 Mar 14;136(6):618-627. doi: 10.1161/CIRCRESAHA.124.325545. Epub 2025 Mar 13.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Neurocardiology is an interdisciplinary field that examines the complex interactions between the nervous and the cardiovascular systems, exploring how neurological processes, such as autonomic nervous system regulation and brain-heart communication impact heart function and contribute to cardiovascular health and disease. Although much of the focus on cardiovascular health has centered on traditional risk factors, the influence of the nervous system, especially in females, is increasingly recognized as a key determinant of cardiovascular outcomes. This article reviews existing literature on the neurological mechanisms that impact cardiovascular function in females. Specifically, we analyze how primary neurological disorders including cerebrovascular disease, headache disorders, and multiple sclerosis have specific downstream effects on cardiac function. By understanding the complex relationship between neurological and cardiovascular health, this review highlights the need for sex-specific approaches to prevention, diagnosis, and treatment of cardiovascular disease in females, ultimately encouraging the discovery of more effective care strategies and improving health outcomes.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40080534/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250315161108&v=2.18.0.post9+e462414">40080534</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.325545>10.1161/CIRCRESAHA.124.325545</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40080534</guid>
<pubDate>Thu, 13 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Khadija Awais Ali</dc:creator>
<dc:creator>Deborah L G Kerrigan</dc:creator>
<dc:creator>Jillian Molli Berkman</dc:creator>
<dc:date>2025-03-13</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Influence of Primary Neurologic Disease on Cardiovascular Health in Females</dc:title>
<dc:identifier>pmid:40080534</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.325545</dc:identifier>
</item>
<item>
<title>The 2024 US Medical Eligibility Criteria for Contraceptive Use: Application to Practice in the Care of Patients With Cardiac Disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40080533/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250315161108&amp;v=2.18.0.post9+e462414
      <description>Cardiovascular disease is the leading cause of maternal mortality in the United States, with the majority of deaths stemming from preventable causes. Contraception is one of the tools that can be utilized to prevent mortality and morbidity associated with unplanned pregnancy in patients with underlying congenital or acquired heart disease. There are a wide range of contraceptive methods available. While some methods, especially those containing estrogen, may be associated with increased risks in...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2025 Mar 14;136(6):566-582. doi: 10.1161/CIRCRESAHA.125.325682. Epub 2025 Mar 13.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Cardiovascular disease is the leading cause of maternal mortality in the United States, with the majority of deaths stemming from preventable causes. Contraception is one of the tools that can be utilized to prevent mortality and morbidity associated with unplanned pregnancy in patients with underlying congenital or acquired heart disease. There are a wide range of contraceptive methods available. While some methods, especially those containing estrogen, may be associated with increased risks in certain cardiac disease states, intrauterine devices, implants, and progestin-only methods may be safely used by the vast majority of patients with cardiac disease. Furthermore, intrauterine devices and implants are the most effective reversible contraceptive methods available. This review provides a summary of the US Centers for Disease Control and Prevention 2024 Medical Eligibility Criteria for Contraceptive Use as it applies to cardiac disease states. This review emphasizes the importance of contraceptive counseling and aims to familiarize the reader with the various forms of contraception available to patients, as well as the risks and benefits of each method in patients with different types of cardiac disease.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40080533/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250315161108&v=2.18.0.post9+e462414">40080533</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.125.325682>10.1161/CIRCRESAHA.125.325682</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40080533</guid>
<pubDate>Thu, 13 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Kayle Shapero</dc:creator>
<dc:creator>Tessa Madden</dc:creator>
<dc:date>2025-03-13</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>The 2024 US Medical Eligibility Criteria for Contraceptive Use: Application to Practice in the Care of Patients With Cardiac Disease</dc:title>
<dc:identifier>pmid:40080533</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.125.325682</dc:identifier>
</item>
<item>
<title>Sex-Specific Factors Influencing Obesity in Women: Bridging the Gap Between Science and Clinical Practice</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40080532/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250315161108&amp;v=2.18.0.post9+e462414
      <description>Obesity in women is a significant public health issue with serious implications for cardiovascular-kidney-metabolic syndrome and cardiovascular disease. This complex challenge is influenced by physiological, hormonal, socioeconomic, and cultural factors. Women face unique weight management challenges due to hormonal changes during pregnancy, perimenopause, and menopause, which affect fat distribution and increase cardiovascular-kidney-metabolic syndrome risk. Current clinical guidelines often...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2025 Mar 14;136(6):594-605. doi: 10.1161/CIRCRESAHA.124.325535. Epub 2025 Mar 13.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Obesity in women is a significant public health issue with serious implications for cardiovascular-kidney-metabolic syndrome and cardiovascular disease. This complex challenge is influenced by physiological, hormonal, socioeconomic, and cultural factors. Women face unique weight management challenges due to hormonal changes during pregnancy, perimenopause, and menopause, which affect fat distribution and increase cardiovascular-kidney-metabolic syndrome risk. Current clinical guidelines often overlook these sex-specific factors, potentially limiting the effectiveness of obesity management strategies in women. This review explores the sex-specific aspects of obesity's pathophysiology, epidemiological trends, and associated comorbidities, focusing on cardiovascular and metabolic complications. This review synthesizes literature on obesity in women, emphasizing sex-specific factors influencing its development and progression. It examines the limitations of body mass index as an obesity measure and explores alternative classification methods. Additionally it investigates the relationship between obesity and comorbidities such as diabetes, hypertension, and dyslipidemia, with a focus on postmenopausal women. Obesity in women is linked to increased risks of cardiovascular-kidney-metabolic syndrome and cardiovascular disease. Hormonal fluctuations throughout life contribute to weight gain and fat distribution patterns specific to women, increasing cardiovascular disease risk. Effective obesity management strategies in women must account for these sex-specific variations. Postmenopausal women are particularly affected by obesity-related complications. Lifestyle interventions, pharmacotherapy, and bariatric surgery have shown efficacy in weight management, though success rates vary. Addressing obesity in women requires a comprehensive approach that considers sex-specific physiological factors, life-stage challenges, and sociocultural barriers. Integrating precision medicine and emerging therapies offers potential for more personalized and effective interventions. Personalized strategies that consider women's biological and life-stage challenges can enhance obesity management and improve cardiovascular outcomes. Future research and clinical practice should focus on developing tailored strategies that address women's unique vulnerabilities to obesity and its associated health risks and on validating sex-specific interventions to improve obesity management in women.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40080532/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250315161108&v=2.18.0.post9+e462414">40080532</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.325535>10.1161/CIRCRESAHA.124.325535</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40080532</guid>
<pubDate>Thu, 13 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Hazem Ayesh</dc:creator>
<dc:creator>Samar A Nasser</dc:creator>
<dc:creator>Keith C Ferdinand</dc:creator>
<dc:creator>Barbara Gisella Carranza Leon</dc:creator>
<dc:date>2025-03-13</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Sex-Specific Factors Influencing Obesity in Women: Bridging the Gap Between Science and Clinical Practice</dc:title>
<dc:identifier>pmid:40080532</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.325535</dc:identifier>
</item>
<item>
<title>Focus on amyloidosis, peripartum cardiomyopathy, and heart failure prediction by artificial intelligence applied to ECG</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40080072/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250315161108&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Mar 13;46(11):987-990. doi: 10.1093/eurheartj/ehaf084.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40080072/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250315161108&v=2.18.0.post9+e462414">40080072</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf084>10.1093/eurheartj/ehaf084</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40080072</guid>
<pubDate>Thu, 13 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Filippo Crea</dc:creator>
<dc:date>2025-03-13</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Focus on amyloidosis, peripartum cardiomyopathy, and heart failure prediction by artificial intelligence applied to ECG</dc:title>
<dc:identifier>pmid:40080072</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf084</dc:identifier>
</item>
<item>
<title>Lipid treatment</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40079901/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250315161108&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Cardiovasc Pharmacother. 2025 Mar 13;11(2):105-106. doi: 10.1093/ehjcvp/pvaf009.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40079901/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250315161108&v=2.18.0.post9+e462414">40079901</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11905741/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250315161108&v=2.18.0.post9+e462414">PMC11905741</a> | DOI:<a href=https://doi.org/10.1093/ehjcvp/pvaf009>10.1093/ehjcvp/pvaf009</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40079901</guid>
<pubDate>Thu, 13 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Stefan Agewall</dc:creator>
<dc:date>2025-03-13</dc:date>
<dc:source>European heart journal. Cardiovascular pharmacotherapy</dc:source>
<dc:title>Lipid treatment</dc:title>
<dc:identifier>pmid:40079901</dc:identifier>
<dc:identifier>pmc:PMC11905741</dc:identifier>
<dc:identifier>doi:10.1093/ehjcvp/pvaf009</dc:identifier>
</item>





























</channel>
</rss>